GLP-1RAs were associated with improved quality of life and emotional eating behaviors among individuals with overweight and obesity.

Researchers have identified the brain cells responsible for the weight-loss effects of semaglutide without triggering its undesirable side effects. This discovery paves the way for more targeted ...